Acid-base balance in peritoneal dialysis patients: A stewart-fencl analysis

Renal Failure

Volumn 31, Issue 8, 2009, Pages 625-632

  Klaboch, Jan ^a   Opatrná, Sylvie ^a   Matoušovic, Karel ^b   Šefrna, Frantisek ^a   Havln, Jan ^b   Schück, Otto ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Acid base balance; Bicarbonate; Icodextrin; Lactate; Peritoneal dialysis; Stewart principle

Indexed keywords

ALBUMIN; BICARBONATE; CHLORIDE; ICODEXTRIN; LACTIC ACID; PHOSPHATE; SODIUM;

ADULT; AGED; ARTICLE; CHLORIDE BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISORDERS OF ACID BASE BALANCE; FEMALE; HUMAN; KIDNEY FUNCTION; MALE; PARAMETER; PERITONEAL DIALYSIS; PH MEASUREMENT; PRIORITY JOURNAL; SODIUM BLOOD LEVEL;

ACID-BASE EQUILIBRIUM; ACID-BASE IMBALANCE; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS;

EID: 70350674205     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/08860220903134076     Document Type: Article

References (48)

1. Devuyst O, Topley N, Williams JD. Morphological and functional changes in the dialysed peritoneal cavity: Impact of more biocompatible solutions. Nephrol Dial Transplant. 2002;17(Suppl. 3): 12-15.
2. Williams JD, Craig KJ, Topley N, Williams GT. Peritoneal dialysis: changes to the structure of the peritoneal membrane and potential for biocompatible solutions. Kidney Int. 2003;Suppl. 84:S158-S161.
3. Jörres A, Bender TO, Finn A, et al. Biocompatibility and buffers: Effect of bicarbonate- buffered peritoneal dialysis fluids on peritoneal cell function. Kidney Int. 1998; 54(6):2184-2193.
4. Witowski J, Korybalska K, Ksiazek K, et al. Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile toward peritoneal mesothelial cells. Nephrol Dial Transplant. 2004;19(4):917-924.
5. Pajek J, Kveder R, Bren A, et al. Short-term effects of new bicarbonate/lactate-buffered and conventional peritoneal dialysis fluid on peritoneal and systemic inflammation in CAPD patients: A randomized controlled study. Perit Dial Int. 2008;28(1):44-52.
6. Mujais S. Acid-base profile in patients on PD. Kidney Int. 2003;Suppl. 88:S26-S36.
7. Kasimatis E, Maksich D, Jassal V, Bargman JM, Oreopoulos DG. Predictive factors of low HCO3 - levels in peritoneal dialysis patients. Clin Nephrol. 2005;63(4):290-296.
8. Tian XK, Shan YS, Zhe XW, Cheng LT, Wang T. Metabolic acidosis in peritoneal dialysis patients: The role of residual renal function. Blood Purif. 2005;23(6):459-465.
9. Fourtounas C, Savidaki E, Roumelioti M, et al. Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate- and bicarbonatebuffered peritoneal dialysis solutions. Adv Perit Dial. 2006;22:187-191.
10. Kung SC, Morse SA, Bloom E, Raja RM. Acid-base balance and nutrition in peritoneal dialysis. Adv Perit Dial. 2001;17:235-237.
11. Ferriani M. Buffers: bicarbonate, lactate and pyruvate. Kidney Int. 1996; Suppl. 56:S75-S80.
12. Bommer J, Locatelli F, Satayathum S, et al. Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2004;44(4):661-671 (Pubitemid 39237610)
13. Kang DH, Lee R, Lee HY, et al. Metabolic acidosis and composite nutritional index (CNI) in CAPD patients. Clin Nephrol. 2000;53(2):124-131.
14. Dumler F, Falla P, Butler R, Wagner C, Francisco K. Impact of peritoneal dialysis modality and acidosis on nutritional status in peritoneal dialysis patients. Adv Perit Dial. 1998;14:205-208.
15. Louden JD, Roberts RR, Goodship TH. Acidosis and nutrition. Kidney Int. 1999;Suppl. 73:S85-S88.
16. Uribarri J. Acidosis in chronic renal insufficiency. Semin Dial. 2000;13(4):232-234.
17. Warnock DG. Uremic acidosis. Kidney Int. 1988;34(2): 278-287.
18. Story DA, Tosolini A, Bellomo R, Leblanc M, Bragantini L, Ronco C. Plasma acid-base changes in chronic renal failure: A Stewart analysis. Int J Artif Organs. 2005; 28(10):961-965.
19. Stewart PA. Modern quantitative acid-base chemistry. Can J Physiol Pharmacol. 1983;61:1444-1461.
20. Fencl V, Jabor A, Kazda A, Figge J. Diagnosis of metabolic acid-base disturbances in critically ill patients. Am J Respir Crit Care Med. 2000;162(6):2246-2251.
21. Schück O, Matousovic K. Relation between pH and the strong ion difference (SID) in body fluids. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005;149(1): 69-73.
22. Kellum JA, Elbers WGP. Stewart's textbook of acid-base. 2nd ed. Netherlands: Lulu.com; 2009.
23. Figge J. An educational web site about modern human acidbase physiology: The Figge-Fencl quantitative physicochemical model of human acid-base physiology. Available at: http://www.figge-fencl.org/, http://www.acid-base.org (accessed March 23, 2009).
24. Opatrna S, Racek J, Stehlik P, Senft V, Sefrna F, Topolcan O. Effect of dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis. Cas Lek Cesk. 2002;141(9):281-285.
25. Ota K, Akiba T, Nakao T, et al. Peritoneal ultrafiltration and serum icodextrin concentration during dialysis with 7.5% icodextrin solution in Japanese patients. Perit Dial Int. 2003;23(4):356-361.
26. Mistry CD, Gokal R, Peers E. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis. Kidney Int. 1994;46(2):496-503.
27. Flanigan MJ, Bailie GR, Frankenfield DL, Frederick PR, Prowant BF, Rocco MV. 1996 Peritoneal Dialysis Core Indicators Study: Report on nutritional indicators. Perit Dial Int. 1998;18(5):489-496.
28. Lowrie EG, Lew NL. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis. 1990;15(5):458-482.
29. Aparicio M, Cano N, Chauveau P, et al. Nutritional status of hemodialysis patients: A French national cooperative study. French Study Group for Nutritional in Dialysis. Nephrol Dial Transplant. 1999;14(7):1679-1686.
30. Yavuz A, Ersoy FF, Passadakis PS et al. Phosphorus control in peritoneal dialysis patients. Kidney Int. 2008;Suppl. 108:S152-S158.
31. Young EW, Albert JM, Satayathum S, et al. Predictors and consequences of altered mineral metabolism: The Dialysis Outcome and Practice Patterns Study. Kidney Int. 2005;67(3): 1179-1187.
32. Twardowski ZJ. Clinical value of standardized equilibration tests in CAPD patients. Blood Purif. 1989;7(2-3):95-108.
33. Milutinovic J, Cutler RE, Hoover P, Meijsen B, Scribner BH. Measurement of residual glomerular filtration rate in the patients receiving repetitive hemodialysis. Kidney Int. 1975;8(3):185-190.
34. Figge J, Mydosh T, Fencl V. Serum proteins and acid-base equilibria: A follow-up. J Lab Clin Med. 1992;120(5):713-719.
35. Gennari FJ. Acid-base balance in dialysis patients. Kidney Int. 1985;28(4):678-688.
36. Feriani M. Use of different buffers in peritoneal dialysis. Semin Dial. 2000;13(4):256-260.
37. Feriani M, Passlick-Deetjen J, Jaeckle-Meyer I, La Greca G. Individualized bicarbonate concentrations in the peritoneal dialysis fluid to optimize acid-base status in CAPD patients. Nephrol Dial Transplant. 2004;19(1):195-202.
38. Heaton A, Johnston DG, Haigh JW, Ward MK, Alberti KG, Kerr DN. Twenty-four hour hormonal and metabolic profiles in uremic patients before and during treatment with continuous ambulatory peritoneal dialysis. Clin Sci (Lond). 1985;69(4):449-457.
39. NKF-K/DOQI Clinical Practical Guidelines for Peritoneal Dialysis Adequacy: Update 2000. Am J Kidney Dis. 2001;37(Suppl. 1):65-136.
40. Feriani M. Adequacy of acid base correction in continuous ambulatory peritoneal dialysis patients. Perit Dial Int. 1994;14(Suppl. 3):S133-S138. (Pubitemid 24254226)
41. Gotch FA, Sargent JA, Keen ML. Hydrogen ion balance in dialysis therapy. Artif Organs. 1982;6(4):388-395.
42. Kang SW, Lee SW, Lee ICH, et al. Impact of metabolic acidosis on serum albumin and other nutritional parameters in long-term CAPD patients. Adv Perit Dial. 1997; 13:249-252.
43. Dumler F, Falla P, Butler R, Wagner C, Francisco K. Impact of peritoneal dialysis modality and acidosis on nutritional status in peritoneal dialysis patients. Adv Perit Dial. 1998;14:205-208.
44. Hernandez-Jaras J, Garcia H, Agramunt I. Peritoneal anionic transfer and their relationship with peritoneal transport and acid-base status. Nefrologia. 2002;22(1):42-48.
45. Feriani M, Passlick-Deetjen J, La Greca G. Factors affecting bicarbonate transfer with bicarbonatecontaining CAPD solution. Perit Dial Int. 1995;15(8):336-341.
46. Kang DH, Yoon KI, Lee HY, Han DS. Impact of peritoneal membrane transport characteristics on acid-base status in CAPD patients. Perit Dial Int. 1998;18(3):294-302.
47. Hutchinson AJ, Freemont AJ, Boulton HF, Gokal R. Lowcalcium dialysis fluid and oral calcium carbonate in CAPD. A method of controlling hyperphosphataemia whilst minimizing aluminium exposure and hypercalcaemia. Nephrol Dial Transplant. 1992;7(12):1219-1225.
48. Borras M, Marco MP, Fernandez E. Treatment with sevelamer decreases bicarbonate levels in peritoneal dialysis patients. Perit Dial Int. 2002;22(6):737-738. (Pubitemid 36131512)